Keeping it in the family: coevolution of latrunculid sponges and their dominant bacterial symbionts
- Authors: Matcher, Gwynneth F , Waterworth, Samantha C , Walmsley, Tara A , Matsatsa, Tendayi , Parker-Nance, Shirley , Davies-Coleman, Michael T , Dorrington, Rosemary A
- Date: 2016
- Language: English
- Type: text , article
- Identifier: http://hdl.handle.net/10962/65603 , vital:28818 , https://doi.org/10.1002/mbo3.417
- Description: publisher version , The Latrunculiidae are a family of cold water sponges known for their production of bioactive pyrroloiminoquinone alkaloids. Previously it was shown that the bacterial community associated with a Tsitsikamma sponge species comprises unusual bacterial taxa and is dominated by a novel Betaproteobacterium. Here, we have characterized the bacterial communities associated with six latrunculid species representing three genera (Tsitsikamma, Cyclacanthia, and Latrunculia) as well as a Mycale species, collected from Algoa Bay on the South African southeast coast. The bacterial communities of all seven sponge species were dominated by a single Betaproteobacterium operational taxonomic unit (OTU0.03), while a second OTU0.03 was dominant in the Mycale sp. The Betaproteobacteria OTUs from the different latrunculid sponges are closely related and their phylogenetic relationship follows that of their hosts. We propose that the latrunculid Betaproteobacteria OTUs are members of a specialized group of sponge symbionts that may have coevolved with their hosts. A single dominant Spirochaetae OTU0.03 was present in the Tsitsikamma and Cyclacanthia sponge species, but absent from the Latrunculia and Mycale sponges. This study sheds new light on the interactions between latrunculid sponges and their bacterial communities and may point to the potential involvement of dominant symbionts in the biosynthesis of the bioactive secondary metabolites. , This research was supported by a SARChI grant from the South African National Research Foundation (NRF, GUN: 87583) and the Rhodes University Sandisa Imbewu Programme. S. C. W. was supported by an NRF Innovation PhD Scholarship and a Rhodes University Henderson PhD Scholarship. T. A. W. was supported by PhD Fellowships from the NRF and the German Academic Exchange Service (DAAD)
- Full Text:
- Date Issued: 2016
Cytotoxicity of lapachol, β-lapachone and related synthetic 1, 4-naphthoquinones against oesophageal cancer cells:
- Authors: Sunassee, Suthananda N , Veale, Clinton G L , Shunmoogam-Gounden, Nelusha , Osoniyi, Omalaja , Hendricks, Denver T , Caira, Mino R , de la Mare, Jo-Anne , Edkins, Adrienne L , Pinto, Antônio V , da Silva Junior, Eufrânio N , Davies-Coleman, Michael T
- Date: 2013
- Language: English
- Type: text , article
- Identifier: http://hdl.handle.net/10962/165207 , vital:41218 , DOI: 10.1016/j.ejmech.2012.12.048
- Description: Naphthoquinones have been found to have a wide range of biological activities, including cytotoxicity to cancer cells. The secondary metabolites lapachol, α- and β-lapachone and a series of 25 related synthetic 1,4-naphthoquinones were screened against the oesophageal cancer cell line (WHCO1). Most of the compounds exhibited enhanced cytotoxicity (IC50 1.6–11.7 μM) compared to the current drug of choice cisplatin (IC50 = 16.5 μM).
- Full Text:
- Date Issued: 2013